PDCD1 and neoplasm: Tumor cells may avoid immune surveillance through upregulation of specific proteins deputed to the maintenance of peripheral immune tolerance, such as programmed cell death ligand-1 (PD-L1), which binds the immune receptor programmed cell death-1 (PD-1) on immune cells.